R
RFSA Dermatology | Castle Hills
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Remibrutinib
Dupilumab
LOU064
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The purpose of this trial is:1. to assess the efficacy, pharmacokinetics, and safety of remibrutinib vs. placebo in adolescents from 12 to \< 18 year...
Enrolling
Chronic Spontaneous Urticaria
Drug: placebo
Drug: LOU064 (blinded)
This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension...
Enrolling
Chronic Inducible Urticaria
Drug: Remibrutinib
Other: Placebo
The purpose of this extension study is to collect long-term efficacy, safety and tolerability data on remibrutinib in a selected group of participant...
Active, not recruiting
Chronic Spontaneous Urticaria
Drug: LOU064 (blinded)
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems